• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ZLCS:US

1.2100 USD 0.1400 10.37%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Zalicus Inc (ZLCS)

Open: 1.2700 Day's Range: 1.1800 - 1.3800 Volume: 2,531,282
Previous Close: 1.3500 52wk Range: 0.8800 - 8.2800 1-Yr Rtn: -63.33%

Stock Chart for ZLCS

No chart data available.
  • ZLCS:US 1.2100
  • 1D
  • 1M
  • 1Y
1.3500
Interactive ZLCS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZLCS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3600
Est. EPS (USD) (12/2014) -0.1600
Est. PEG Ratio -
Market Cap (M USD) 31.59
Shares Outstanding (M) 26.11
30 Day Average Volume 865,362
Price/Book (mrq) 1.9068
Price/Sale (ttm) 2.2909
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZLCS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZLCS

Zalicus Inc is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The Company's drug pipeline includes an arthritis formula in phase 2 development.

Mark H N CorriganPresident/CEOJustin A RenzExec VP/CFO/Treasurer
More Company Profile & Key Executives for ZLCS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil